News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BASi (BASI) Signs Preferred Provider Agreement With G1 Therapeutics


10/16/2013 11:08:44 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--BASi (Bioanalytical Systems, Inc.) (NASDAQ: BASI) announced today that it has entered into a Preferred Provider Agreement (PPA) with G1 Therapeutics, a privately held company that develops small molecule therapeutics to protect bone marrow from damage due to chemotherapy or radiation. Under the agreement, BASi will become the preferred provider of preclinical services, including toxicology, bioanalytical and analytical testing, to support G1’s drug development programs.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES